| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Achievements and future of chemotherapy
|
Verweij, J
|
|
2000
|
36 |
12 |
p. 1479-1487
9 p.
|
article
|
| 2 |
Analysis of the fragile histidine triad (FHIT) gene in lobular breast cancer
|
Huiping, C
|
|
2000
|
36 |
12 |
p. 1552-1557
6 p.
|
article
|
| 3 |
Assessment of percutaneous fine needle aspiration cytology as a technique to provide diagnostic and prognostic information in neuroblastoma
|
Thiesse, P
|
|
2000
|
36 |
12 |
p. 1544-1551
8 p.
|
article
|
| 4 |
Challenges and pitfalls of mass-screening in the European Union
|
Coebergh, J.W.W.
|
|
2000
|
36 |
12 |
p. 1469-1472
4 p.
|
article
|
| 5 |
Combination raltitrexed (Tomudex®)–oxaliplatin: a step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherapy in mesothelioma
|
Fizazi, K
|
|
2000
|
36 |
12 |
p. 1514-1521
8 p.
|
article
|
| 6 |
Economics and health-related quality of life in antiemetic therapy: recommendations for trial design
|
Uyl-de Groot, C.A
|
|
2000
|
36 |
12 |
p. 1522-1535
14 p.
|
article
|
| 7 |
Efficacy and toxicity profile of oral topotecan in a panel of human tumour xenografts
|
De Cesare, M
|
|
2000
|
36 |
12 |
p. 1558-1564
7 p.
|
article
|
| 8 |
Evaluation of the efficacy of potential antineoplastic drugs on tumour metastasis by a computer-assisted image analysis
|
Lentini, A
|
|
2000
|
36 |
12 |
p. 1572-1577
6 p.
|
article
|
| 9 |
Forewarned is forearmed — benefits of preparatory information on video cassette for patients receiving chemotherapy or radiotherapy — a randomised controlled trial
|
Thomas, R.
|
|
2000
|
36 |
12 |
p. 1536-1543
8 p.
|
article
|
| 10 |
Human papilloma virus status and chromosomal imbalances in primary cervical carcinomas and tumour cell lines
|
|
|
2000
|
36 |
12 |
p. 1587-
1 p.
|
article
|
| 11 |
Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer
|
Kramer, J.A
|
|
2000
|
36 |
12 |
p. 1498-1506
9 p.
|
article
|
| 12 |
Influence of schedule of administration on methotrexate penetration in brain tumours
|
Dukic, S.F
|
|
2000
|
36 |
12 |
p. 1578-1584
7 p.
|
article
|
| 13 |
Meta-analysis of studies on breast cancer risk and diet
|
|
|
2000
|
36 |
12 |
p. 1588-
1 p.
|
article
|
| 14 |
Modulation of drug resistance by α-tubulin in paclitaxel-resistant human lung cancer cell lines
|
Han, E. Kyu-Ho
|
|
2000
|
36 |
12 |
p. 1565-1571
7 p.
|
article
|
| 15 |
Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom Checklist
|
Kramer, J.A
|
|
2000
|
36 |
12 |
p. 1488-1497
10 p.
|
article
|
| 16 |
Recommendations on cancer screening in the European Union
|
|
|
2000
|
36 |
12 |
p. 1473-1478
6 p.
|
article
|
| 17 |
Refined deletion mapping in sporadic breast cancer at chromosomal region 8p12-p21 and association with clinicopathological parameters
|
Seitz, S.
|
|
2000
|
36 |
12 |
p. 1507-1513
7 p.
|
article
|
| 18 |
Re: Tamoxifen for the prevention of breast cancer. Eur J Cancer
36 2000, 142–150. Relationship of trial design to value of data for patient?
|
Thornton, H.
|
|
2000
|
36 |
12 |
p. 1585-1586
2 p.
|
article
|
Journal description